Janus Henderson Group PLC Avidity Biosciences, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,656,843 shares of RNA stock, worth $172 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,656,843
Previous 1,242,833
194.23%
Holding current value
$172 Million
Previous $31.7 Million
370.98%
% of portfolio
0.08%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding RNA
# of Institutions
237Shares Held
91.4MCall Options Held
198KPut Options Held
223K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$514 Million0.05% of portfolio
-
Rtw Investments, LP New York, NY8.81MShares$415 Million6.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$406 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.51MShares$307 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$280 Million0.0% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.46B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...